Mainstream

Neurocrine Biosciences targets $2.5B-$2.6B INGREZZA sales for 2025 amid expanded sales force

Neurocrine Biosciences targets $2.5B-$2.6B INGREZZA sales for 2025 amid expanded sales force

Post ContentnbixRead More

You might also be interested in reading BlackRock Assets Under Management Rise Through $10T.

February 7, 2025
In Mainstream